Infarction is defined as an area of necrosis due to decreased blood flow. It can be hemorrhagic or anemic, red or white. Cardiac biomarkers such as troponin T and I, creatine kinase (CK-MB), and myoglobin are released from damaged heart muscle and can help evaluate myocardial injury. These biomarkers have characteristic rise and fall patterns. Renal failure can alter the diagnostic accuracy of cardiac biomarkers. Treatment of acute myocardial infarction focuses on restoring normal blood flow and salvaging heart muscle.